Heidi Dvinge received a postdoctoral fellowship from the Department of Defense’s Breast Cancer Research Program. Heidi proposed to determine how the RNA components of the spliceosome contribute to breast cancer. These spliceosomal RNAs are best known for playing basal roles in splicing catalysis, and are not typically studied in the context of splicing regulation or dysregulation in disease. Heidi found evidence that spliceosomal RNAs may play important roles in the progression of “triple-negative” breast cancers, which are frequently aggressive and difficult to treat with currently available therapies.

• 

  James Thomas receives K99 Award from the NCI

  Jun 1, 2022
• 

  Robert Bradley appointed as Director of Translational Data Science Integrated Research Center

  Dec 1, 2021
• 

  Robert Bradley appointed to McIlwain Family Endowed Chair in Data Science

  Jul 8, 2020
• 

  Jacob Polaski receives Young Investigator Award from the Edward P. Evans Foundation

  Mar 14, 2020
• 

  Guo-Liang Chew becomes Special Fellow at the Cancer Science Institute of Singapore

  Jan 3, 2020